Zimmer Biomet Holdings (ZBH) Free Cash Flow (2009 - 2026)

Zimmer Biomet Holdings' Free Cash Flow history runs 18 years deep, the most recent figure standing at $323.1 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 4.46% year-over-year to $323.1 million in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 0.23% change from a year earlier, with the FY2025 full-year figure at $1.5 billion, up 13.66% from the prior year.
• Free Cash Flow slipped to $323.1 million in Q1 2026 per ZBH's latest filing, from $442.6 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $525.6 million in Q4 2023 and bottomed at $172.9 million in Q1 2024.
• The 5-year median for Free Cash Flow is $323.1 million (2026), against an average of $326.5 million.
• Across the five-year window, Free Cash Flow plunged 37.31% in 2022 and surged 190.71% in 2023, its largest moves.
• Year by year, Free Cash Flow stood at $180.8 million in 2022, then surged by 190.71% to $525.6 million in 2023, then fell by 13.47% to $454.8 million in 2024, then fell by 2.68% to $442.6 million in 2025, then dropped by 27.0% to $323.1 million in 2026.
• Per Business Quant, the three latest ZBH Free Cash Flow figures stand at $323.1 million (Q1 2026), $442.6 million (Q4 2025), and $363.7 million (Q3 2025).